Better Therapeutics, Inc. Annual Operating Income (Loss) in USD from 2020 to 2022

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Better Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2020 to 2022.
  • Better Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2023 was -$5.34M, a 51.4% increase year-over-year.
  • Better Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2023 was -$29.6M, a 29.6% increase year-over-year.
  • Better Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$38.3M, a 25.2% decline from 2021.
  • Better Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$30.6M, a 383% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$38.3M -$7.7M -25.2% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-30
2021 -$30.6M -$24.2M -383% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 -$6.32M Jan 1, 2020 Dec 31, 2020 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.